{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:32:57Z","timestamp":1792528377457,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.nmni.2024.101233","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T20:19:44Z","timestamp":1708201184000},"page":"101233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: A systematic review"],"prefix":"10.1016","volume":"58","author":[{"given":"Shiny","family":"Talukder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paroma","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monira","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaniz E","family":"Zannat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirul Huda","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmuda","family":"Yeasmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-9144","authenticated-orcid":false,"given":"Md Maruf Ahmed","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-7094","authenticated-orcid":false,"given":"KM","family":"Saif-Ur-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib1","first-page":"401","article-title":"Characteristics of COVID-19 infection in Beijing","volume":"80","author":"Tian","year":"2020","journal-title":"J\u00a0Infect"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.nmni.2024.101233_bib3","unstructured":"WHO coronavirus (COVID-19) dashboard [Internet]. vol. 2023. Accessed September 20, 2023, 2023. https:\/\/covid19.who.int."},{"key":"10.1016\/j.nmni.2024.101233_bib4","first-page":"91","article-title":"COVID-19 infection: emergence, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J\u00a0Adv Res"},{"key":"10.1016\/j.nmni.2024.101233_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1057\/s41271-020-00229-y","article-title":"The COVID-19 infection: lessons from the Italian experience","volume":"41","author":"Romagnani","year":"2020","journal-title":"J\u00a0Publ Health Pol"},{"issue":"5","key":"10.1016\/j.nmni.2024.101233_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ"},{"issue":"9","key":"10.1016\/j.nmni.2024.101233_bib7","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1002\/jmv.27102","article-title":"Viral coinfections in COVID\u201019","volume":"93","author":"Aghbash","year":"2021","journal-title":"J\u00a0Med Virol"},{"issue":"9","key":"10.1016\/j.nmni.2024.101233_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cix120","article-title":"Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock","volume":"64","author":"Ong","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12091","article-title":"Virus infection, antiviral immunity, and autoimmunity","volume":"255","author":"Getts","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nmni.2024.101233_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5313832","article-title":"Viral coinfection among COVID-19 patient groups: an update systematic review and meta-analysis","author":"Malekifar","year":"2021","journal-title":"BioMed Res Int"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib11","article-title":"Risk factors for Herpes simplex virus (HSV) and Cytomegalovirus (CMV) infections in critically-ill COVID-19 patients","volume":"17","author":"Fuest","year":"2022","journal-title":"Multidisciplinary Respiratory Medicine"},{"key":"10.1016\/j.nmni.2024.101233_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06638-y","article-title":"Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.nmni.2024.101233_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/jmv.27421","article-title":"Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID\u201019","volume":"94","author":"Yamamoto","year":"2022","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.nmni.2024.101233_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.nmni.2024.101233_bib15","doi-asserted-by":"crossref","unstructured":"World Health Organization. (2020). Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. Accessed February 22 2023 https:\/\/apps.who.int\/iris\/handle\/10665\/332196.","DOI":"10.15557\/PiMR.2020.0004"},{"issue":"9267","key":"10.1016\/j.nmni.2024.101233_bib17","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.nmni.2024.101233_bib18","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3390\/v14122645","article-title":"Viral coinfections","volume":"14","author":"Du","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2217\/fvl.11.21","article-title":"Virus reactivation: a panoramic view in human infections","volume":"6","author":"Traylen","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.nmni.2024.101233_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.nmni.2024.101233_bib21","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1002\/cl2.1229","article-title":"Prioritization and sequential exclusion of articles in systematic reviews","volume":"18","author":"Saif\u2010Ur\u2010Rahman","year":"2022","journal-title":"Campbell Syst Rev"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.nmni.2024.101233_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15521","article-title":"Herpes zoster in the era of COVID 19: a prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination","volume":"35","author":"Almutairi","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4103\/1319-2442.338304","article-title":"Cytomegalovirus and severe acute respiratory syndrome coronavirus 2 Co-infection in renal transplants: a retrospective study from a single center","volume":"32","author":"Meshram","year":"2021","journal-title":"Saudi J Kidney Diseas Transpl"},{"issue":"3","key":"10.1016\/j.nmni.2024.101233_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High incidence of Epstein\u2013Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect Dis Now"},{"issue":"3","key":"10.1016\/j.nmni.2024.101233_bib26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jmv.27392","article-title":"Presence and clinical impact of human herpesvirus\u20106 infection in patients with moderate to critical coronavirus disease\u201019","volume":"94","author":"Lino","year":"2022","journal-title":"J\u00a0Med Virol"},{"issue":"6","key":"10.1016\/j.nmni.2024.101233_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/bjd.19806","article-title":"COVID\u201019\u2010associated cutaneous manifestations: does human herpesvirus 6 play an aetiological role?","volume":"184","author":"Abad\u00edas\u2010Granado","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.nmni.2024.101233_bib28","first-page":"600","article-title":"Experience with cutaneous manifestations in COVID-19 patients during the pandemic","volume":"11","author":"Navarro-Bielsa","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03252-3","article-title":"Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients","volume":"24","author":"Balc\u2019h","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.nmni.2024.101233_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jhin.2021.11.007","article-title":"Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS","volume":"119","author":"Reizine","year":"2022","journal-title":"J\u00a0Hosp Infect"},{"issue":"6","key":"10.1016\/j.nmni.2024.101233_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"issue":"8","key":"10.1016\/j.nmni.2024.101233_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.idnow.2021.07.005","article-title":"Herpesvirus reactivation during severe COVID-19 and high rate of immune defect","volume":"51","author":"Saade","year":"2021","journal-title":"Infect Dis Now"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib33","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1002\/iid3.597","article-title":"COVID\u201019 associated EBV reactivation and effects of ganciclovir treatment","volume":"10","author":"Meng","year":"2022","journal-title":"Immun Inflamm Disease"},{"issue":"9","key":"10.1016\/j.nmni.2024.101233_bib34","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3390\/microorganisms9091896","article-title":"Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: a prospective, observational study","volume":"9","author":"Franceschini","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib35","article-title":"Positive Epstein\u2013Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.nmni.2024.101233_bib36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/microorganisms10020362","article-title":"Reactivation of herpes simplex virus type 1 (HSV-1) detected on bronchoalveolar lavage fluid (BALF) samples in critically ill COVID-19 patients undergoing invasive mechanical ventilation: preliminary results from two Italian centers","volume":"10","author":"Giacobbe","year":"2022","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib37","first-page":"496","article-title":"Cytomegalovirus infection in critically ill patients with COVID-19","volume":"83","author":"Niitsu","year":"2021","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.nmni.2024.101233_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03843-8","article-title":"HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients","volume":"25","author":"Meyer","year":"2021","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-017-1803-1","article-title":"Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all","volume":"21","author":"Textoris","year":"2017","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-021-00218-z","article-title":"Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?","volume":"18","author":"S\u00f6derberg-Naucl\u00e9r","year":"2021","journal-title":"Immun Ageing"},{"issue":"7","key":"10.1016\/j.nmni.2024.101233_bib41","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.3390\/ijms24076832","article-title":"Effect of cytomegalovirus reactivation on inflammatory status and mortality of older COVID-19 patients","volume":"24","author":"Giacconi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13613-019-0616-6","article-title":"Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO","volume":"9","author":"Hraiech","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"6","key":"10.1016\/j.nmni.2024.101233_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00134-022-06716-y","article-title":"Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality","volume":"48","author":"Gatto","year":"2022","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ca.23790","article-title":"A\u00a0narrative review and clinical anatomy of Herpes zoster infection following COVID\u201019 vaccination","volume":"35","author":"Iwanaga","year":"2022","journal-title":"Clin Anat"},{"key":"10.1016\/j.nmni.2024.101233_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1753-y","article-title":"Herpes zoster-associated mortality in Europe: a systematic review","volume":"15","author":"Bricout","year":"2015","journal-title":"BMC Publ Health"},{"issue":"10","key":"10.1016\/j.nmni.2024.101233_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2006.06.001","article-title":"The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Wang","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13666","article-title":"Herpes zoster might be an indicator for latent COVID 19 infection","volume":"33","author":"Elsaie","year":"2020","journal-title":"Dermatol Ther"},{"issue":"7","key":"10.1016\/j.nmni.2024.101233_bib48","article-title":"Herpes zoster co-infection in an immunocompetent patient with COVID-19","volume":"12","author":"Saati","year":"2020","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.nmni.2024.101233_bib49","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/ene.14361","article-title":"COVID\u201019 and herpes zoster co\u2010infection presenting with trigeminal neuropathy","volume":"27","author":"Ferreira","year":"2020","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.nmni.2024.101233_bib50","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib51","doi-asserted-by":"crossref","first-page":"e1359","DOI":"10.1002\/cti2.1359","article-title":"Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID\u201019 lung disease","volume":"11","author":"Jaiswal","year":"2022","journal-title":"Clinic Translation Immunol"},{"key":"10.1016\/j.nmni.2024.101233_bib52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12250-020-00276-5","article-title":"Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus co-infection","volume":"35","author":"Chen","year":"2020","journal-title":"Virol Sin"},{"issue":"3","key":"10.1016\/j.nmni.2024.101233_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13131","article-title":"Viral co\u2010infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID\u201019 pandemic in Yaound\u00e9, Cameroon, 2020\u20132021","volume":"17","author":"Moumbeket Yifomnjou","year":"2023","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"4","key":"10.1016\/j.nmni.2024.101233_bib54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.gendis.2020.11.005","article-title":"Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury","volume":"8","author":"Lin","year":"2021","journal-title":"Genes & Diseases"},{"issue":"1","key":"10.1016\/j.nmni.2024.101233_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01594-0","article-title":"Influenza co-infection associated with severity and mortality in COVID-19 patients","volume":"18","author":"Alosaimi","year":"2021","journal-title":"Virol J"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297524000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297524000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:03:31Z","timestamp":1761854611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297524000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":54,"alternative-id":["S2052297524000179"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2024.101233","relation":{},"ISSN":["2052-2975"],"issn-type":[{"value":"2052-2975","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: A systematic review","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2024.101233","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101233"}}